Camlin Fine Sciences Ltd.

₹80.53

-3.2 (-3.9%)

CAMLINFINE Share Price

Chemicals & Petrochemicals

As on October 23, 2026

SectorChemicals

IndustryChemicals & Petrochemicals

Basic IndustrySpecialty Chemicals

Market Cap₹ 1,543.7 Cr

P/E Ratio55.99

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	87.52	Bearish
10-DMA	88.71	Bearish
20-DMA	91.2	Bearish
50-DMA	98.65	Bearish
100-DMA	114.1	Bearish
200-DMA	123.64	Bearish

Historical Performance

1 Year

-59.9%

3 Years

-44.6%

5 Years

-53.8%

10 Years

-28.4%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	17,233	16,287	14,539	16,816	14,121
Total Expenditure	16,065	14,023	13,132	14,692	12,579
Other Income	288	152	442	64	367
Operating Profit	1,456	2,416	1,849	2,188	1,909
Interest	829	1,067	700	662	408
Depreciation	709	610	564	625	560
Profit Before Tax	-320	646	586	804	940
Consolidated Net Profit	276	-1,390	-928	521	607
Adjusted EPS	1	-7	-5	3	4

Compounded Sales Growth

10 Years:28.6

5 Years:7.7

3 Years:0.5

TTM:1.1

Compounded Profit Growth

10 Years:-5.1

5 Years:-11.5

3 Years:-11.9

TTM:-41.4

Stock Price CAGR

10 Years:-3.2

5 Years:-14.3

3 Years:-17.9

TTM:-58.9

Return on Equity

10 Years:-1.1

5 Years:3.8

3 Years:-5.4

last year:1.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	192	188	167	157	157
Total Reserves	10,059	8,688	8,340	7,894	7,200
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,613	2,378	3,220	4,131	4,034
Other Current Liabilities	2,369	1,847	1,644	2,466	1,644
Short Term Borrowings	2,231	2,415	2,335	2,333	1,810
Total Liabilities	22,365	19,588	19,112	20,301	17,637
Capital Work in Progress	329	97	456	408	2,147
Long Term Loans & Advances	471	382	397	316	424
Currents Investments	---	380	---	---	---
Short Term Loans and Advances	1,221	1,106	948	945	601
Total Current Assets	12,343	11,834	9,986	10,858	8,915
Total Assets	22,365	19,588	19,112	20,301	17,637
Adjusted Book Value	53	47	47	47	42

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 55.99, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -17.6%, indicating poor shareholder returns.
The stock carries a high beta of 1.7, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹1456 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹17233 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 411434.1

No. of Shares: 5109 (Approx)

Performance:-58.9%

-588565.9

NIFTY Performance: -12.4%

1 day Top Gainers